Spider-Man’s Real-World Science in Turning Off Powers

In Spider-Man: Brand New Day, Peter Parker struggles with strange symptoms caused by the DNA from a spider bite that triggers his powers. He wants to keep some abilities but turn off others. To help, he visits Bruce Banner, who has created a device called an inhibitor to stop the Hulk from appearing.

The inhibitor works by targeting specific genes linked to superpowers. In one scene, Parker asks Banner about the science behind it: “You’re using target-specific short interfering RNA, right?” This isn’t just movie magic—short interfering RNAs (siRNAs) are real molecules used in medicine to treat genetic diseases.

Here’s how they work. Cells use DNA to create RNA, which acts as a guide for building proteins. Messenger RNA (mRNA), like the one used in COVID vaccines, carries these instructions. siRNAs act like tiny switches, blocking specific mRNA from being read and stopping unwanted protein production.

In the movie, this technology helps Parker turn off his powers. In real life, scientists use similar methods to treat diseases caused by faulty genes. At least seven such treatments are approved by the U.S. Food and Drug Administration, with more in testing phases. This groundbreaking science isn’t just for superheroes—it’s helping people today.